Oramed Pharmaceuticals Inc (ORMP) insider trading
Every open-market stock purchase and sale by Oramed Pharmaceuticals Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Joshua Hexter (COO) and 1 other sold $226K in the last 90 days.
- Last insider buy: Arie Mayer (Director), $8.4K, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $1.2M (4 sales). Last close $4.12 on Oct 22, 2026.
Recent ORMP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 1, 2026 | Joshua Hexter (COO) | Sold | $135K |
| Oct 1, 2026 | Avraham Gabay (CFO) | Sold | $90.2K |
| Sep 24, 2026 | Nadav Kidron (CEO) | Sold (not open market) | $1.6M |
| Sep 24, 2026 | Nadav Kidron (CEO) | Sold (not open market) | $1.5M |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | $1M |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | $1M |
| Sep 24, 2026 | Nadav Kidron (CEO) | Sold (not open market) | $912K |
| Sep 24, 2026 | Nadav Kidron (CEO) | Sold (not open market) | $790K |
| Sep 24, 2026 | Nadav Kidron (CEO) | Sold (not open market) | $621K |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | $544K |
| Sep 24, 2026 | Joshua Hexter (COO) | Sold (not open market) | $520K |
| Sep 24, 2026 | Joshua Hexter (COO) | Sold (not open market) | $500K |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | $480K |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | $383K |
| Sep 24, 2026 | Nadav Kidron (CEO) | Sold (not open market) | $381K |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Sold (not open market) | $329K |
| Sep 24, 2026 | Joshua Hexter (COO) | Sold (not open market) | $185K |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Bought (not open market) | — |
| Sep 24, 2026 | Joshua Hexter (COO) | Bought (not open market) | — |
| Sep 24, 2026 | Joshua Hexter (COO) | Bought (not open market) | — |
| Sep 24, 2026 | Nadav Kidron (CEO) | Bought (not open market) | — |
| Sep 24, 2026 | Nadav Kidron (CEO) | Bought (not open market) | — |
| Sep 24, 2026 | Avraham Gabay (CFO) | Bought (not open market) | — |
| Sep 24, 2026 | Miriam Kidron (C-suite exec) | Bought (not open market) | — |
| Jul 2, 2026 | Joshua Hexter (COO) | Bought (not open market) | $185K |
Who's trading ORMP
- Avraham Gabay, CFO: sold $421K (2 sales), last Oct 1, 2026
- Joshua Hexter, COO: sold $747K (2 sales), last Oct 1, 2026
- Miriam Kidron, C-suite exec: other filings, last Sep 24, 2026
- Nadav Kidron, CEO: other filings, last Sep 24, 2026
- Daniel Aghion, Director: other filings, last Dec 31, 2025
- Arie Mayer, Director: other filings, last Dec 31, 2025
- Yehuda Reznick, Director: other filings, last Dec 31, 2025
- Benjamin Shapiro, Director: other filings, last Dec 31, 2025
Get free alerts when an insider at Oramed Pharmaceuticals Inc files a new trade →